Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients

Human Immunology

Volumn 74, Issue 6, 2013, Pages 758-763

  Pan, Ning ^a   Chen, Keping ^a   Qiu, Jie ^a   Sun, Hang ^a   Xu, Jinhuan ^a   Miao, Fengqin ^a   Shi, Qian ^a   Jiang, Wei ^a   Jin, Hui ^a   He, Youji ^a   Xie, Wei ^a   Zhang, Jianqiong ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HEPATITIS B; HLA TYPING; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84877050688     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.02.007     Document Type: Article

References (23)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
2. Di Bisceglie A.M. Hepatitis B and hepatocellular carcinoma. Hepatology 2009, 49:S56-S60.
3. Yuen M.F., Hou J.L., Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 2009, 24:346-353.
4. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
5. Li Z., Chen D., Zhang C., Li Y., Cao B., Ning T., et al. HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population. China Immunogenetics 2005, 56:781-787.
6. Bulut I., Meral M., Kaynar H., Pirim I., Bilici M., Gorguner M. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer. Lung Cancer 2009, 66:231-236.
7. Li X., Ghandri N., Piancatelli D., Adams S., Chen D., Robbins F.M., et al. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med 2007, 5:22.
8. Hildesheim A., Apple R.J., Chen C.J., Wang S.S., Cheng Y.J., Klitz W., et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002, 94:1780-1789.
9. Wu Y.F., Wang L.Y., Lee T.D., Lin H.H., Hu C.T., Cheng M.L., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 2004, 72:17-25.
10. Thio C.L., Thomas D.L., Karacki P., Gao X., Marti D., Kaslow R.A., et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003, 77:12083-12087.
11. Stachowski J., Kramer J., Fust G., Maciejewski J., Baldamus C.A., Petranyi G.G. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II, and III alleles in haemodialysis patients. Scand J Immunol 1995, 42:60-65.
12. Mineta M., Tanimura M., Tana T., Yssel H., Kashiwagi S., Sasazuki T. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 1996, 8:525-531.
13. Pan N., Jiang W., Sun H., Miao F., Qiu J., Jin H., et al. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS One 2011, 6:e25682.
14. Chinese Society of Hepatology and Chinese Society of Infectious Diseases CMA: The guideline of Prevention and treatment for chronic hepatitis B, zhonghua Gan Zang Bing Za Zhi 13 (2005) 881-891.
15. The criteria for clinical diagnosis and staging of hepatocellular carcinoma, Gan Zang 9 (2004) 67-68.
16. Dunn P.P., Cox S.T., Little A.M. Sequencing protocols for detection of HLA class I polymorphism. Methods Mol Biol 2003, 210:191-222.
17. Helmberg W., Dunivin R., Feolo M. The sequencing-based typing tool of dbMHC: typing highly polymorphic gene sequences. Nucleic Acids Res 2004, 32:W173-W175.
18. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
19. Shen Y., Xia M., Zhang J., Xu L., Yang J., Chen A., et al. IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells. Mol Immunol 2009, 46:2045-2053.
20. Kurokohchi K., Carrington M., Mann D.L., Simonis T.B., Alexander-Miller M.A., Feinstone S.M., et al. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 1996, 23:1181-1188.
21. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99.
22. Hei A.L., Li W., Deng Z.H., He J., Jin W.M., Du D., et al. Analysis of high-resolution HLA-A, -B, -Cw, -DRB1, and -DQB1 alleles and haplotypes in 718 Chinese marrow donors based on donor-recipient confirmatory typing. Int J Immunogenet 2009, 36:275-282.
23. *11 in Chinese children with steroid-responsive nephrotic syndrome. Pediatr Nephrol 2002, 17:212-216.